MTEX
NASDAQMannatech Incorporated
SectorHealth CareIndustry Medicinal Chemicals and Botanical Products
Price$5.40-1.07 (-16.54%)
2026-03-132026-06-16
News · 26 weeks290%
2025-12-212026-06-14
Mix2390d
- SEC Filings10(43%)
- Insider5(22%)
- Other4(17%)
- Earnings2(9%)
- Leadership2(9%)
Latest news
25 items- SECMannatech Incorporated filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - MANNATECH INC (0001056358) (Filer)
- PRMannatech Announces Appointment of Yasir Haider as Chief Financial OfficerFLOWER MOUND, Texas, June 08, 2026 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (NASDAQ:MTEX) announces that on June 3, 2026, Yasir Haider was appointed Chief Financial Officer of Mannatech, Incorporated (the "Company"). Mr. Haider joined the Company on January 6, 2025, as the Company's Controller. Prior to joining the Company, Mr. Haider held senior finance leadership roles, including Chief Financial Officer and Financial Controller, where he was responsible for global financial operations, multi-entity consolidations, financial reporting, and capital planning across complex organizations. His experience includes SEC reporting, mergers and acquisitions, and the development of scalable fi
- INSIDERSEC Form 4 filed by Director Toth Robert4 - MANNATECH INC (0001056358) (Issuer)
- INSIDERSEC Form 4 filed by Director John Seifrick A4 - MANNATECH INC (0001056358) (Issuer)
- SECMannatech Incorporated filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - MANNATECH INC (0001056358) (Filer)
- PRMannatech Announces Results of Annual Shareholders' MeetingFLOWER MOUND, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (Nasdaq: MTEX) (the "Company"), a global health and wellness company committed to transforming lives to make a better world, announced that its shareholders passed all proposals put to a vote at the Company's annual shareholder meeting (the "Meeting") held Tuesday, June 2, 2026. Mannatech's Chairman of the Board, J. Stanley Fredrick, chaired the Meeting and Yasir Haider, Interim Chief Financial Officer, reported to the shareholders on the Company's 2025 financial results. At the close of business on April 6, 2026, the record date for determining shareholders entitled to vote at the Meeting, there were 1,929,6
- INSIDERDirector Jobe Larry A bought $11,548 worth of shares (2,803 units at $4.12), increasing direct ownership by 4% to 70,000 units (SEC Form 4)4 - MANNATECH INC (0001056358) (Issuer)
- INSIDERDirector Jobe Larry A bought $21,000 worth of shares (5,000 units at $4.20), increasing direct ownership by 8% to 67,197 units (SEC Form 4)4 - MANNATECH INC (0001056358) (Issuer)
- INSIDERDirector Robbins Kevin Andrew bought $29,607 worth of shares (7,100 units at $4.17), increasing direct ownership by 27% to 33,333 units (SEC Form 4)4 - MANNATECH INC (0001056358) (Issuer)
- SECMannatech Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - MANNATECH INC (0001056358) (Filer)
- SECSEC Form 10-Q filed by Mannatech Incorporated10-Q - MANNATECH INC (0001056358) (Filer)
- PRMannatech Reports Financial Results for First Quarter 2026FLOWER MOUND, Texas, May 14, 2026 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its first quarter of 2026. First Quarter Results •Net sales for the three months ended March 31, 2026 were $24.9 million, a decrease of $1.6 million, as compared to the same period in 2025. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $2.2 million, or 8.1%, and foreign exchange caused a $0.5 million increase in GAAP net sales as compared to the same period in 2025. •Gross profit as a percentage of n
- SECMannatech Incorporated filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - MANNATECH INC (0001056358) (Filer)
- SECSEC Form SCHEDULE 13D filed by Mannatech IncorporatedSCHEDULE 13D - MANNATECH INC (0001056358) (Subject)
- SECSEC Form DEFA14A filed by Mannatech IncorporatedDEFA14A - MANNATECH INC (0001056358) (Filer)
- SECSEC Form DEF 14A filed by Mannatech IncorporatedDEF 14A - MANNATECH INC (0001056358) (Filer)
- PRMannatech Reports Financial Results for Fourth Quarter and Year Ended 2025FLOWER MOUND, Texas, April 17, 2026 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its fourth quarter and year ended 2025. Fourth Quarter Results Fourth quarter net sales for 2025 were $26.6 million, a decrease of $2.4 million, or 8.2%, as compared to $29.0 million in the fourth quarter of 2024. During the fourth quarter, the Company's net sales declined 7.6% on a Constant dollar basis (a Non-GAAP financial measure); unfavorable foreign exchange during the fourth quarter caused a decrease of $0.2 million in net sales as
- SECMannatech Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - MANNATECH INC (0001056358) (Filer)
- SECSEC Form 10-K filed by Mannatech Incorporated10-K - MANNATECH INC (0001056358) (Filer)
- SECAmendment: SEC Form NT 10-K/A filed by Mannatech IncorporatedNT 10-K/A - MANNATECH INC (0001056358) (Filer)
- PRMannatech Announces Notification of Late FilingFLOWER MOUND, Texas, April 01, 2026 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (NASDAQ:MTEX), ("Mannatech" or "the Company") announced today that it has filed a Form 12b-25, Notification of Late Filing, with the U.S. Securities and Exchange Commission with regard to its annual report on Form 10-K (the "2025 Form 10-K") for the fiscal year ended December 31, 2025. Form 12b-25 allows the Company an automatic extension of 15 additional calendar days to file the 2025 Form 10-K, which is due on March 31, 2026. The Company expects to file the 2025 Form 10-K as soon as practicable by April 15, 2026, in accordance with Rule 12b-25. The 12b-25 filing is available on the Company's website under ir
- SECSEC Form NT 10-K filed by Mannatech IncorporatedNT 10-K - MANNATECH INC (0001056358) (Filer)
- SECMannatech Incorporated filed SEC Form 8-K: Leadership Update8-K - MANNATECH INC (0001056358) (Filer)
- INSIDERDirector Jobe Larry A was granted 4,790 shares, increasing direct ownership by 8% to 62,197 units (SEC Form 4)4 - MANNATECH INC (0001056358) (Issuer)
- INSIDERDirector Robbins Kevin Andrew was granted 4,790 shares, increasing direct ownership by 22% to 26,233 units (SEC Form 4)4 - MANNATECH INC (0001056358) (Issuer)
MTEX FAQ
5 questionsWhat does Mannatech Incorporated do?
Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through network marketing channels and a website. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.Where does MTEX stock trade?
Mannatech Incorporated (MTEX) is listed on NASDAQ.What sector and industry is MTEX in?
Mannatech Incorporated operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry.What companies are similar to MTEX?
Notable peers in the same industry include PM (Philip Morris International Inc), BTI (British American Tobacco Industries p.l.c.), MO (Altria Group Inc.), RGC (Regencell Bioscience Holdings Limited), RLX (RLX Technology Inc.). Compare MTEX side-by-side with any of them on Quantisnow.How can I track MTEX on Quantisnow?
Quantisnow aggregates Mannatech Incorporated's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MTEX to receive live email and push alerts on every new disclosure.